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Refractory Rhinosinusitis
Yi-Tsen Lin and Te-Huei Yeh
Abstract
Various factors have been proposed to be related to refractory chronic rhinosi-
nusitis (CRS). Treatment for refractory CRS is challenging for ear, nose, and throat 
(ENT) surgeons. The aim of the study was to determine the clinical features associ-
ated with the severity of CRS that may necessitate revision surgery by eliminating 
the bias of the surgeon’s technique using standardizing surgical procedures. Sinus 
wall thickness and blood eosinophilia, which may represent the depth of inflamma-
tion in CRS, are associated with the need for revision surgery. We found that, when 
the thickness of the posterolateral maxillary sinus wall is more than 3.03 mm, there 
is an increased probability for a need for revision surgery. CRS patients with thick-
ened sinus walls were found to have poorer outcomes. Further research is needed in 
order to justify this type of surgical procedure for CRS.
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1. Introduction
The sinonasal organ plays an important role in the human respiratory system, 
as this organ consistently encounters external irritants and is therefore one of the 
most frequently inflamed sites in the human body [1]. Inflammation may begin as 
an infectious process (acute rhinosinusitis), and, if the symptoms persist without 
resolution, it can lead to inflammatory consequences (chronic rhinosinusitis (CRS)) 
[2]. CRS is one of the most prevalent chronic diseases in modern society and is 
defined as the presence of more than one nasal symptom (mucopurulent drainage, 
nasal congestion, facial pain-pressure-fullness, and decreased sense of smell) and a 
documentation of inflammation for more than 12 weeks [3]. It is a heterogeneous, 
multifactorial disease with multiple distinct factors, including genetic, infectious, 
immune, anatomic, allergic, and inflammatory components [2]. The goal of CRS 
therapy is maximal medical treatment including oral and topical antibiotics, nasal 
steroids, systemic steroids, antihistamines, and saline irrigations. Functional 
endoscopic sinus surgery (FESS) is indicated if medical therapy fails [4].
The safety and efficacy of FESS for CRS have been strongly supported by 
meta-analyses from both large outcome studies and cohort studies. Improvement in 
both disease-specific and generic quality of life and objective measures have been 
demonstrated for the efficacy of FESS; however, across long-term follow-up, there 
is a 10–20% revision rate, which is considered to be refractory CRS [5]. Refractory 
CRS is defined by failure to stabilize after surgery and treatment with antibiot-
ics, saline rinses, and topical steroid and has become a significant issue for ENT 
surgeons [6]. Predicting surgical outcome is crucial for evaluating the severity of 
CRS preoperatively, and the severity of CRS is usually defined by several factors. 
Temporally, the duration and frequency of symptoms and signs of CRS patients 
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cannot be precisely correlated. Spatially, the Lund-Mackay (L-M) score, which is 
based on CT images, is the most frequently used method to evaluate the severity of 
CRS; nevertheless, the L-M score represents only a snapshot of the condition [7]. A 
swift change in mucosal swelling is frequently observed during the subacute stage 
of sinusitis. Other parameters should be considered in order to define the severity 
of CRS and more accurately predict its prognosis.
Various factors are related to refractory CRS, including mucociliary dysfunction, 
the presence of mucosal biofilm, peripheral eosinophil count, mucosal eosinophilia, 
acute postoperative infection, ASA triad, cystic fibrosis, osteitis, hyperreactive 
airway, inhaled allergen, and experience of the performing surgeon [8–12]. It is 
important to find a simple way to evaluate the severity of CRS in order to identify 
an accurate prognosis for patients and determine which patients may need long-
term medical treatment. The aim of the study was to determine the clinical features 
related to the severity of CRS that would necessitate revision surgery, by carefully 
eliminating surgeon bias using standardizing surgical procedures.
2. Standardization of surgical procedure and treatment protocol
The first consideration of this study was to select appropriate patients in order 
to exclude the congenitally influential factor of heterogeneity of CRS. The next 
consideration was to standardize the preoperative treatment, surgical procedure, 
and postoperative follow-up protocol. Over the past 10 years, we have developed a 
standardized surgical procedure and treatment protocol. Preoperatively, the referral 
doctor administers optimal medical treatment to the patient; if that does not occur, 
our clinics will administer the treatment. If treatment fails, surgery is suggested. 
Preoperative medication is not given for at least 2 weeks, if acute exacerbation was 
not noted before surgery. Some patients are given a loose schedule of intranasal 
steroid spray, but oral antibiotics are not given regularly.
Other information are also collected during the preoperative visit: age, gender, 
asthma, nasal polyps, allergic rhinitis, obstructive sleep apnea, diabetes, smoking 
status, gastroesophageal reflux disease, prior FESS history, and Samter’s triad. 
For the surgical procedure, the objects of FESS include several folds: to clear out 
the occluded ostium by correcting the anatomical flaw of bottleneck of draining 
pathway for diseased sinus, to decrease inflammatory load by removing developed 
polyps or swollen mucosa which was filled with inflammatory milieu, and to clean 
out entrapped discharge from deep-seated recess which contained inflammation-
inducing materials. Based on the principles described above, we developed eight 
complete steps to perform standard FESS:
1. Middle turbinate trimming: This procedure is used instead of medial frac-
ture in order to expose the posterior margin of uncinate process and hiatus 
semilunaris.
2. Uncinectomy: The first step of ethmoidectomy is to properly remove the 
uncinate process. It can be antegrade, with a sickle knife, or retrograde, by 
using backbiting forceps, until the superiorly agger nasi cell, and frontal recess 
and inferiorly the natural ostium of maxillary sinus are identified.
3. Enlargement of the natural ostium of maxillary sinus: By removing the mucosa 
of posterior fontanelle, the accessory ostium can be identified during this step. 
Pathologic tissue in the maxillary sinus is removed, and irrigation by normal 
saline is frequently applied.
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4. Removal of the bony wall of the ethmoid bulla: Identifying the basal lamella of 
the middle turbinate. The retrobullar recess and suprabullar cells are exposed. 
It is important to expose and identify lamina papyracea in order to delineate 
the lateral margin of the ethmoid cavity.
5. Removal of the basal lamella at the medial inferior site: In order to enter 
posterior ethmoid sinus space safely, the middle turbinate insertion is not 
destabilized. When entering posterior ethmoid space, the superior turbinate 
and skull base are identified by carefully removing the ethmoid bony septum 
of the posterior ethmoid sinuses.
6. Opening of the sphenoid sinus, if necessary: The sphenoid sinus is not 
frequently involved in CRS. If necessary, remove the inferior third of supe-
rior turbinate in order to easily find the natural ostium of sphenoid sinus. 
Irrigation or removing polypoid mucosa surround the ostium is sufficient for 
most patients.
7. Removal of the bony partitions along the skull base: After identifying the skull 
base at the posterior ethmoid roof, its is safe to remove the partitions anteriorly 
to reach the bony indentation of the anterior ethmoid artery (AEA), which is 
the most important landmark to manage frontal recess. The AEA is a landmark 
(“Nike” logo-shaped curve) and may be buried inside a bony canal in patients 
with well-pneumatized anterior ethmoid sinuses; it could be mesenteric. This 
space is complicated by various possible suprabullar or frontobullar cells and is 
a challenging step for beginners.
8. Cleaning frontal sinus-draining route: Using the 45-degree endoscope, mark 
the anatomic landmark of AEA posteriorly and agger nasi or frontoethmoid 
cells anteriorly; the frontal sinus-draining route is frequently buried in the 
complicated anterior ethmoid cell system. There may be anteriorly, posteriorly, 
medially, and laterally located ethmoid air cells; it is important to identify the 
boundary of ethmoid cavity laterally to the lamina papyracea, medially to the 
middle turbinate concha, and superiorly along the skull base. The frontal sinus 
will be safely opened.
Postoperative care includes regularly follow-up for at least 6 months using 
optimal antibiotic treatment, including low-dose macrolide for 2 months and nasal 
steroids, as well as routine saline nasal douching plus adjuvant of gentamicin for at 
least 3 months.
3. Patient selection, radiographic evaluation, and statistical analyses
We reviewed the medical records of 243 patients who received bilateral FESS 
in our department by the same senior surgeon of a tertiary referral hospital from 
September 2010 to August 2011. Computed tomography (CT) of paranasal sinuses 
was performed in all patients at most 2 months prior to surgery. Other preoperative 
evaluations included hematologic examination the day before surgery. Patients 
with known systemic diseases or malignancies were excluded, such as diabetes 
mellitus, asthma, or other immunocompromised diseases. Forty-eight CRS patients 
who received revised sinus surgery during this period were recruited; 21 of these 
patients received surgery by the same surgeon, and the other 27 patients received 
surgery from different surgeons. Among the 21 patients, patients with no previous 
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sinus CT scan available for comparison were excluded. Among the 27 patients, 
we excluded the patients who received previous Caldwell-Luc procedures. Nine 
patients were assigned to Group A (primary and revised surgery by the same senior 
surgeon), 17 patients were assigned to Group B (previously operated on by other 
surgeons), and 30 control patients were assigned to Group C who received primary 
FESS surgery during the same period and were followed up for at least 3 years 
without revision surgery. Group D included 30 control patients with head and neck 
CT scan from parotid surgery without notified sinonasal problems. Hematologic 
examination was evaluated for Group D patients 1 day prior to surgery. The flow 
chart of patient selection is shown in Figure 1. The clinical information including 
the result of bacterial culture and pathology to evaluate eosinophilic rhinosinusitis, 
with or without asthma and ImmunoCAP Specific IgE blood test, were also col-
lected for further analysis.
The extent of paranasal sinus mucosal disease was evaluated by using the 
L-M staging system [7]. Sinus wall thickness was measured in coronal view of 
the sinus CT. The posterolateral wall of maxillary sinus, para-crista galli level 
(around the lateral lamella) of the ethmoid sinus, and the anterior clinoid level 
of sphenoid sinus were measured as the representative thickness of each sinus 
wall (Figure 2). All CT studies were performed by 64 multidetector-row CTs 
(LightSpeed VCT, GE Medical Systems). Contiguous axial 1.2-mm-thick slices 
were obtained through the maxillofacial bones, and images were reconstructed 
with soft tissue and bone reconstruction algorithms; 3.0-mm-thick coronal and 
sagittal reformatted images were obtained per our institutional protocol. All CT 
measurements were made on bone algorithm reconstructed and bone-windowed 
images (W:2000, L:500) using an independent workstation. The measurements 
were repeated by two independent otolaryngologists. In detail, maxillary sinus 
wall thickness is measured at the posterolateral region where the first cut is 
shown when the zygoma is separated from the maxillary sinus wall, measuring 
the thickest part. The ethmoid sinus wall thickness is measured at the para-crista 
galli region around the lateral lamella, also the thickest part. The sphenoid 
Figure 1. 
Flow chart of patient selection.
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sinus wall thickness is measured at the first cut showing the anterior clinoid, 
the thickest part. At the lateral sphenoid wall, the carotid canal and optic nerve 
may introduce measurement confusion, and it is the reason why we choose the 
anterior clinoid level instead of the lateral sphenoid wall for wall thickness mea-
surement where more constant sinus wall thickness could be measured. Frontal 
sinus wall was excluded due to its high variation of pneumatization in normal 
population.
We assessed gender, age, hemoglobin (Hb) levels, white blood cell (WBC) 
count, eosinophilic count, L-M score, bony wall thickness of maxillary/ethmoid/
sphenoid sinus, and mean recurrence time of CRS. Comparisons between groups 
were performed by analysis of variance (ANOVA) tests for normally distributed 
variables and Kruskal-Wallis test for nonparametric variables, as required. Chi-
square tests for categorical variables. Multiple logistic regression analysis was 
performed between Groups A and C against various parameters including age, 
gender and maxillary sinus wall thickness, LM score, Hb, and eosinophil count. 
Receiver-operating characteristic (ROC) curves were constructed to define cutoff 
value for potential refractory CRS. Linear regression was used to determine the 
relationship between scalar variables. All statistical analyses were performed using 
SPSS software. p < 0.05 was considered to be statistically significant.
Figure 2. 
Representative sinus CT scan to measure sinus wall thickness. A 61-year-old male patient with 
recurrent CRS and status post two times of FESS; the figure shows the preoperative sinus CT image of the 
first FESS. (A) Maxillary sinus wall thickness is measured at the posterolateral region. The first cut is shown 
when the zygoma (white arrow) is separated from the maxillary sinus wall, measuring the thickest part. (B) 
Ethmoid sinus wall thickness is measured at the para-crista galli region around the lateral lamella, the thickest 
part (white arrow). (C) The sphenoid sinus wall thickness is measured at the first cut showing the anterior 
clinoid, the thickest part (white arrow).
Rhinosinusitis
6
4. Clinical features associated with the severity of CRS
4.1 Patient demographics
Group A included 8 males and 1 female (mean age, 49.1 ± 15.1 years), Group B 
included 11 males and 6 females (mean age, 47.8 ± 15.6 years), Group C included 23 
males and 7 females (mean age, 41.9 ± 11.3 years), and Group D included 10 males 
and 20 females (mean age, 50 ± 14.9 years). There was no significantly difference 
across age (unpaired t-test, p > 0.05). The gender distribution was significantly 
different with obvious male preponderance in Groups A, B, and C (Kruskal-Wallis 
test, p < 0.05; Table 1). The information including bacteriology, eosinophilic  
rhinosinusitis, asthma, or ImmunoCAP Specific IgE blood test were shown in 
Table 1. The bacteriological data indicated Staphylococcus aureus was the major 
bacterial species found. The main infiltrative inflammatory cells according to 
pathologic slides were lymphoplasma cells and, occasionally, neutrophil infiltration. 
Eosinophilic rhinosinusitis was defined as average eosinophil count >10/high power 
field in ten randomly selected fields (X 400) under H&E staining from our previ-
ous publication [13]. Aspirin intolerance and bronchial asthma were very scarce 
(only one case in Groups A and C, respectively).
4.2 Hematologic examination
There was no statistically significant difference in hematologic examination 
results between groups (unpaired t-test, p > 0.05). The absolute peripheral eosino-
phil counts in Group A were significantly higher than in Group D (Table 2).
4.3 L-M score and sinus wall thickness
The average L-M score of Group A was 16.7 ± 8.0 and of Group C was 12.9 ± 5.1; 
there was no significant difference between these groups (unpaired t-test, p > 0.05, 
Table 3).
The assessments of sinus wall thickness between the independent otolaryngolo-
gists were very close. The average intraclass correlation coefficient between two 
assessors was 0.833 (95% confidence interval, 0.782–0.872). In terms of individual 
sinuses, the closest interrater agreement was found for sphenoid sinuses (0.821, 
Group N= Age Gender* Bacteriology# Eosinophilic 
rhinosinusitis$
Aspirin 
intolerance 
or asthma
A 9 49.1 ± 15.1 8M1F (1)& 3 1 1
B 17 47.8 ± 15.6 11M6F (3) 3 1 1
C 30 41.9 ± 11.3 23M7F (4) 2 1 0
D 30 44.7 ± 13.6 10M20F NA NA NA
Group A: Revision group (same surgeon). Group B: Revision group (different surgeons). Group C: Primary FESS 
group. Group D: Normal control group.
*p < 0.05 (Kruskal-Wallis test).
#Other than normal flora, there are Staphylococcus aureus (n = 5), MRSA (n = 1), Citrobacter koseri (n = 1), and 
Haemophilus influenzae (n = 1).
$Average eosinophil count >10/high power field in ten randomly selected fields (X 400) under H&E staining13.
&Number of patient with positive ImmunoCAP test.
Table 1. 
Patients’ demographic data.
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0.932), followed by the ethmoid sinuses (0.631, 0.851) and the maxillary sinuses 
(0.576, 0.825). In Group A, the mean sinus wall thickness of the maxillary, ethmoid, 
and sphenoid sinuses were 4.25 ± 1.66 mm, 1.83 ± 0.37 mm, and 1.89 ± 0.66 mm, 
respectively. Group B had a mean thickness of 2.43 ± 0.83 mm, 1.49 ± 0.28 mm, and 
1.49 ± 0.59 mm in the maxillary, ethmoid, and sphenoid sinuses. In Group C, the 
sinus wall thickness was as follows: maxillary sinus, 2.06 ± 0.49 mm; ethmoid sinus, 
1.46 ± 0.24 mm; and sphenoid sinus, 1.34 ± 0.28 mm. In Group D, the measured 
sinus wall mean thickness of the maxillary, ethmoid, and sphenoid sinuses were 
1.97 ± 0.42 mm, 1.44 ± 0.33 mm, and 1.39 ± 0.34 mm, respectively.
The sinus wall thickness of Group A was significantly higher than Groups C and 
D; in Group B, only the maxillary sinus wall thickness was significantly different 
compared to Group D (unpaired t-test, p < 0.05; Table 3). Multiple logistic regres-
sion analysis was performed between Groups A and C against various parameters 
including age, gender and maxillary sinus wall thickness, LM score, Hb, and 
eosinophil count. Eventually, maxillary sinus wall thickness was an independent 
significant factor noted (p = 0.037; Table 4).
4.4 Mean recurrence time
Average recurrence time of Group A was 28.7 ± 13.9 months. There was no sig-
nificant correlation between the mean recurrence time and preoperative L-M score 
(Figure 3) or sinus wall thickness (linear regression, p > 0.05; Figure 4).
Group Hematologic exam
Hemoglobin WBC count (k/μl) Eos. (%) Peripheral eos. 
count (k/μl)
Sugar (g/dL)
A 14.58 ± 0.67 6333.3 ± 1494.5 4.48 ± 3.82 303.09 ± 297.48* 91.2 ± 8.3
B 14.34 ± 1.29 6119.4 ± 1781.6 2.91 ± 2.03 181.45 ± 179.31 93.1 ± 14.3
C 14.29 ± 1.53 6994.3 ± 1637.0 3.66 ± 3.03 249.48 ± 240.49 90.1 ± 9.2
D 14.00 ± 1.23 6146.7 ± 1598.4 3.50 ± 2.51 164.29 ± 204.15 96.4 ± 21.6
Group A: Revision group (same surgeon). Group B: Revision group (different surgeons). Group C: Primary FESS 
group. Group D: Normal control group.
*p < 0.05, compared with group D.
Table 2. 
Hematologic examination result in different groups.
Group L-M score Sinus wall thickness (mm)
Maxillary Ethmoid Sphenoid
A 16.7 ± 8.0 4.25 ± 1.66 1.83 ± 0.37 1.89 ± 0.66
B 12.9 ± 6.6$ 2.43 ± 0.83 1.49 ± 0.28 1.49 ± 0.59
C 12.9 ± 5.1 2.06 ± 0.49¶ 1.46 ± 0.24¶ 1.34 ± 0.28¶
D 0.23 ± 0.43 1.97 ± 0.42¶, # 1.44 ± 0.33¶ 1.39 ± 0.34¶
Group A: Revision group (same surgeon). Group B: Revision group (different surgeons). Group C: Primary FESS 
group. Group D: Normal control group.
¶p < 0.05, compared with group A.
#p < 0.05, compared with group B.
$With primary CT; n = 8.
Table 3. 
L-M score and sinus wall thickness result in different groups.
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4.5  The cutoff values of sinus wall thickness for the prediction of 
recalcitrant CRS
The cutoff value of sinus wall thickness in prediction of refractory CRS who 
needs revision surgery differed across sinuses. The sensitivity and specificity for 
prediction also varied. Using 3.03 mm as a cutoff value for the maxillary sinus, the 
sensitivity was 88.9% and the specificity was 90%. Using 1.63 mm as cutoff value 
for ethmoid sinus, the sensitivity and specificity were 77.8 and 80.0%, respectively. 
Using 1.75 mm as a cutoff value for the sphenoid sinus, the sensitivity was 44.4% 
and the specificity was 80.0%.
P value Odds ratio 95% CI
Age 0.648 1.039 0.881–1.226
Gender 0.711 0.001 0.026–8.020
Maxillary thickness 0.037 19.442 1.192–317.181
L-M score 0.958 0.994 0.800–1.235
Hb 0.648 1.400 0.330–5.951
Eosinophil count 0.827 0.999 0.989–1.009
Group A: Revision group (same surgeon). Group C: Primary FESS group.
Table 4. 
Multiple logistic regression between Groups A and C.
Figure 3. 
Linear regression between the mean recurrence period and L-M score in Group A showed no significant 
relationship (p > 0.05).
Figure 4. 
Mean recurrence period showed no significant relationship compared to the maxillary, ethmoid, 
and sphenoid sinus wall thickness (linear regression, p > 0.05).
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Different sinus wall thicknesses showed areas under ROC curve (AUC) of 0.94, 
0.72, and 0.63, for maxillary, ethmoid, and sphenoid sinuses, respectively. The 
AUC of maxillary sinus wall thickness reached statistical significance (ROC curve, 
p < 0.05; Figure 5).
5.  Sinus wall thickness and blood eosinophilia as the indicators for 
revision surgeries
The success of FESS for CRS is still variable, ranging from 76 to 98% [4]. 
Although the exact predictive factors are still controversial, several risk factors, 
such as nasal polyps, allergic rhinitis, aspirin intolerance, and bacterial resistance, 
can result in unfavorable treatment outcomes for CRS patients. In this study, we 
found that the presence of thickened maxillary sinus walls of more than 3.03 mm 
and increased peripheral blood eosinophil count are good predictors of unfavor-
able outcomes from FESS. In addition to the classical L-M scoring system, a two-
dimensional parameter, we suggest that these two factors may represent another 
three-dimensional parameter that may indicate the depth of inflammation in CRS 
in order to evaluate its severity.
The sinonasal organ is an expanding air-filled space that grows in a random pat-
tern proven by using a simple computerized equation [14]. The sinus pneumatization 
process may be considered as using limited material ballooning to occupy the space 
among the eyeballs, brain, and mouth. This expanding process creates one frontal, 
maxillary, and sphenoid sinus cell on each side and, more importantly, the complex-
ity of the ethmoid cell system. The bony sinus wall, which confines this sinonasal cav-
ity, represents the boundary and most peripheral lining of this organ. If it is involved 
in the inflammatory process, it might be considered as one of the dimensions of the 
depth of disease extent, indicating a more severe form of sinonasal disease. One study 
showed that CRS patients had smaller maxillary sinuses than normal controls. These 
authors proposed that the increased bone thickness in the maxillary sinus itself might 
be related to the size of the sinus [15]. Accordingly, we demonstrated that maxillary 
sinus wall thickness is an indicator of poor surgical outcome.
Figure 5. 
ROC curve shows the cutoff values for the best sensitivity and specificity of each sinus: 3.03, 1.63, 
and 1.75 mm in maxillary, ethmoid, and sphenoid sinus, respectively. The ROC curve of maxillary sinus has 
maximal area under a curve (AUC) of 0.94.
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The success rate of surgical outcomes for CRS patients across surgeons var-
ies. The experience and technique of the surgeon are important factors related to 
the successfulness of treatment. Surgical studies contain congenital bias, that is, 
procedures or interventions are not executed in a uniform way; there is also a lack 
of patient-blinding to the surgical intervention and performance bias, which is also 
the case between different surgeons. Therefore, it is crucial to establish a standard 
surgical protocol in order to avoid the impact of the confounding effect of surgical 
techniques on patient outcomes. Therefore, over the past 10 years, we have made an 
effort to standardize surgical procedures in order to eliminate differences among 
surgeons. The standard eight-step FESS procedure is based on Stammberger and 
Kennedy’s methods, which sequentially remove the obstruction of the drainage 
pathway anterior to posterior to reach the sphenoid sinus ostium; then, it is moved 
from posterior back to anterior along the identified skull base until the AEA is 
identified and the frontal sinus is opened. If the diseased sinuses are limited, the 
surgical procedure can be tailored so that the normal sinus mucosa and drain-
ing pathway are exposed and identified; this is also a way to educate beginners to 
understand FESS in an organized method.
In 1992, it was first suggested that chronic inflammation of the bony frame-
work of paranasal sinuses plays a pivotal role in the pathophysiology of CRS; this 
hypothesis was further confirmed by subsequent animal studies [16]. Georgalas 
et al. proposed a global osteitis scoring scale as an indicator of revised sinus 
surgery [17]. Snidvongs et al. proposed that the osteitic sinus bone is a surrogate 
of tissue or serum eosinophilia in CRS patients [18]. Osteitis changes in the sinus 
bone are present in heterogeneous, irregular bone in areas of growth and destruc-
tion. Some studies have proposed that bone thickness can predict the severity of 
osteitis [19, 20]. Recently, sinus osteitis and subsequent bony remodeling were 
also suggested as a contributing factor to refractory CRS. At a microscopic level, 
osteitis is associated with eosinophilic inflammation and may represent a method 
to predict patients with P-glycoprotein overexpression by using an epithelial-to-
background staining ratio; increased osteitis burden is associated with increased 
P-glycoprotein membranous expression in CRS [21–23]. In our study, the sinus 
bony walls in Group A were significantly thicker than those in Groups C and D; 
in Group B, only the maxillary sinus wall was significantly thicker than that of 
the control group. These results reflect the importance of the role of a surgeon in 
evaluating surgical outcomes. Our data also suggest that a posterolateral maxil-
lary sinus wall thickness of 3.03 mm should be the cutoff value in order to predict 
refractory CRS.
The existence of bacterial biofilms (BBF) has also been proposed to be associ-
ated with osteitis in CRS [10]. Biofilm formation might reflect the severity, chronic-
ity, or both of sinus infection; therefore, the release of inflammatory mediators 
would stimulate osteoblast activity, inducing bony remodeling and osteitis. Osteitis 
may further spread the pathogen either via the Haversian canal system hematog-
enously or from direct local invasion [24]. Intraepithelial bacteria are also found in 
CRS patients [25]. Considering the histology of sinus mucosa, these factors repre-
sent the depth of involvement of inflammatory process and indicate a prolonged 
treatment course. Although it did not reach statistical significance, maxillary sinus 
wall thickness is also related to shortened time to recurrence (Figures 3 and 4); 
therefore, compared to L-M scores of sinus CT, sinus wall thickness may represent 
greater proximity for the chronicity of CRS. At present, the mainstay of sinus sur-
gery still focuses on restoring ventilation, yet no specific surgical method has been 
proven to be effective in treating osteitis associated with CRS. Instead, long-term or 
topical antibiotic treatment is administrated in cases of sinus osteitis and refractory 
sinusitis [26].
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It has previously been reported that eosinophilic inflammation in the sinonasal 
tissues is correlated with the advanced severity of CRS and the poor outcomes 
associated with FESS [12]. Recent evidence has shown that eosinophilic inflam-
mation in Caucasians CRS patients with polyps does not affect Asian to the same 
extent. A study from Thailand indicated a time-shifting migration of neutrophilic 
inflammation to eosinophilic inflammation, and a study from Korea suggested 
that eosinophilic inflammation might not be related to surgical outcome in Korean 
CRS patients [27, 28]. In our study, increased peripheral eosinophil numbers had 
a limited impact on surgical outcomes, suggesting that the clinical implication of 
eosinophilic inflammation might be different in Asian patients. Nevertheless, our 
study strengthens the hypothesis that increased eosinophil numbers are a poor 
indicator of CRS outcomes. Blood eosinophilia is induced from proliferation of 
eosinophil progenitor from bone marrow (myeloproliferative) or clonal expansion 
of peripheral eosinophil in the blood stream [29, 30]. The proposal that refractory 
CRS represents a local manifestation of systemic inflammatory disease is supported 
by our results. Our study suggested that, for those patients with obvious sinus wall 
thickening, more detailed preoperative consultation and laboratory tests and more 
aggressive postoperative medical treatment are needed.
There are several limitations of this study. First, we had small case numbers. 
Second, there are individual differences in the tolerance of sinusitis, as revision 
surgery was used as the judgment for refractory sinusitis. Despite the limitations, 
the knowledge gained in our study provides crucial information to guide surgical 
selection in CRS patients.
In summary, a variety of factors lead to refractory CRS. As a result, treatment 
for refractory CRS is a great challenge for ENT surgeons. Thickness of posterolateral 
maxillary sinus wall of more than 3.03 mm indicates possibility for revised surgery. 
For those CRS patients with thickened sinus wall in which we expect poor out-
comes, further research is needed in order to justify the surgical procedure in such a 
probable systemic inflammatory disease.
6. Conclusions
In this study of subjects of chronic rhinosinusitis (CRS) undergoing functional 
endoscopic sinus surgery (FESS), we determined which clinical features are associ-
ated with higher possibility for revised surgery. We have developed an eight-step 
standard procedure to perform FESS in order to eliminate the bias of surgical 
technique. Sinus wall thickness and blood eosinophilia are associated with the need 
for revision surgery. Thickness of posterolateral sinus wall of more than 3.03 mm 
in maxillary sinus indicates the higher possibility for revised surgery. Also, CRS 
patients with thickened sinus walls were found to have poorer outcomes.
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